REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/29/2025
Back to search
Official data from USPTO
BLOCK IGE UNLOCK LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
12/30/2025
Trademark type
Combined
Nice classes
5, 44
Filing date
03/27/2020
Registration date
12/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2020
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
SCLEIDOROVICH,JOANNA YAEL
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "BLOCK IGE" above the words "UNLOCK LIFE" bracketed by L-shaped lines above and to the right of "BLOCK IGE" and under and to the left of "UNLOCK LIFE" on a rectangular background; the words and L-shaped lines are white and the background is lilac.
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 44
Providing health information
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/08/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
04/08/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/25/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/25/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/25/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/25/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/25/2020
RFNT
REFUSAL PROCESSED BY IB
07/18/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/29/2020
RFRR
REFUSAL PROCESSED BY MPU
06/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/28/2020
CNRT
NON-FINAL ACTION WRITTEN
05/27/2020
DOCK
ASSIGNED TO EXAMINER
05/27/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/21/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/20/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/14/2020
Continuous trademark protection
Get notified about every new filing that threatens BLOCK IGE UNLOCK LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.